CHRU de Brest
Brest, 29609, France
NCT Number: NCT02302183
The aim of the study is to assess the use feasibility of the FreeO2 system so as to deliver automatically oxygen in infants and children admitted at hospital for hypoxemic acute respiratory distress.
In healthy volunteers adults, FreeO2 system provided a better control of the oxygen saturation in function of designed target, reducing the desaturation time and hyperoxia. Our hypothesis is that FreeO2 system use is feasible in infants and children with hypoxemic acute respiratory distress. We think FreeO2 will provide a better control of the oxygen saturation, a faster oxygen weaning than classical way (Rotameter). In addition, FreeO2 could reduce the number of intervention by nurses.
Looking for future studies?
Notify Me1 month–15 year
All sexes
Interventional
Not applicable
Brest, 29609, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Automatic adjustment of oxygen through the "Free O2" device., "FreeO2" device in mode medical data collecting(SpO2).
Other names: Manual adjustment of oxygen without the assistance of the "FreeO2" device., Only "FreeO2" device in mode medical data collecting(SpO2)
Time frame: 6 hours or 1 hour after cessation of oxygenation
The target zone of oxygen saturation is : SpO2 = 92-98% The "acute phase of treatment" is defined by the 6 first hours of treatment by oxygenation and/or until one hour after the end of this last.
Time frame: 6 hours or 1 hour after after cessation of oxygenation
Time frame: 6 hours or 1 hour after oxygenation cessation
Time frame: 6 hours or 1 hour after cessation of the oxygenation
Time frame: 28 days max
Time frame: 28 days max
University Hospital, Brest
Other
Automatic Oxygen Administration in Spontaneous Ventilation During the Hypoxemic Acute Respiratory Distress in Infants and Children
Acronym: Infant-Free02
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05352490
Decompensated Heart Failure ; COPD Exacerbation, Dyspnea
Monastir, Tunisia
View Trial DetailsNCT04886128
Acute Heart Failure, Cardiovascular Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT07656610
COVID-19, COVID-19 Pneumonia
Çorum, Turkey (Türkiye)
View Trial DetailsNCT07612384
Asthma, Bronchial Diseases
Islamabad, Pakistan
View Trial Details